It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A retrospective meta-analysis of magnetic resonance imaging voxel-based morphometry studies proposed that reduced gray matter volumes in the dorsal anterior cingulate and the left and right anterior insular cortex—areas that constitute hub nodes of the salience network—represent a common substrate for major psychiatric disorders. Here, we investigated the hypothesis that the common substrate serves as an intermediate phenotype to detect genetic risk variants relevant for psychiatric disease. To this end, after a data reduction step, we conducted genome-wide association studies of a combined common substrate measure in four population-based cohorts (n = 2271), followed by meta-analysis and replication in a fifth cohort (n = 865). After correction for covariates, the heritability of the common substrate was estimated at 0.50 (standard error 0.18). The top single-nucleotide polymorphism (SNP) rs17076061 was associated with the common substrate at genome-wide significance and replicated, explaining 1.2% of the common substrate variance. This SNP mapped to a locus on chromosome 5q35.2 harboring genes involved in neuronal development and regeneration. In follow-up analyses, rs17076061 was not robustly associated with psychiatric disease, and no overlap was found between the broader genetic architecture of the common substrate and genetic risk for major depressive disorder, bipolar disorder, or schizophrenia. In conclusion, our study identified that common genetic variation indeed influences the common substrate, but that these variants do not directly translate to increased disease risk. Future studies should investigate gene-by-environment interactions and employ functional imaging to understand how salience network structure translates to psychiatric disorder risk.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Technical University of Munich, Department of Neurology, Klinikum rechts der Isar, School of Medicine, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
2 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Cécile and Oskar Vogt Institute of Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917); Department of Biomedicine, University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
3 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X)
4 Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany (GRID:grid.5603.0)
5 German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426); University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.5603.0)
6 Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany (GRID:grid.5949.1) (ISNI:0000 0001 2172 9288); Institut für Energie- und Umwelttechnik e.V. (IUTA, Institute of Energy and Environmental Technology), Duisburg, Germany (GRID:grid.506549.b)
7 Department of Biomedicine, University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); University of Oslo, Department of Psychology, Center for Lifespan Changes in Brain and Cognition, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921)
8 Westfälische Wilhelms-Universität Münster, Department of Psychiatry and Psychotherapy, Münster, Germany (GRID:grid.5949.1) (ISNI:0000 0001 2172 9288)
9 Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany (GRID:grid.5603.0)
10 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Medical Faculty, Heinrich Heine University Düsseldorf, Institute for Anatomy I, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917)
11 Department of Biomedicine, University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); University of Bonn, Department of Genomics, Life & Brain Center, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
12 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Department of Biomedicine, University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); University of Bonn, Department of Genomics, Life & Brain Center, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300); Institute of Human Genetics, University of Bonn, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
13 Philipps-Universität Marburg, Department of Psychiatry and Psychotherapy, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756); University of Marburg and Justus Liebig University Giessen, Center for Mind, Brain and Behavior (CMBB), Marburg, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627); Marburg University Hospital – UKGM, Marburg, Germany (GRID:grid.8664.c)
14 Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany (GRID:grid.5949.1) (ISNI:0000 0001 2172 9288)
15 University Hospital Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany (GRID:grid.410718.b) (ISNI:0000 0001 0262 7331)
16 Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany (GRID:grid.5603.0)
17 Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Wu Tsai Neurosciences Institute, Stanford University, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Veterans Affairs Palo Alto Healthcare System, and the Sierra Pacific Mental Illness, Research, Education, and Clinical Center (MIRECC), Palo Alto, USA (GRID:grid.168010.e)
18 University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.5603.0)
19 University of Bonn, Department of Genomics, Life & Brain Center, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300); Institute of Human Genetics, University of Bonn, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
20 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Cécile and Oskar Vogt Institute of Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917); JARA-Brain, Jülich-Aachen Research Alliance, Jülich, Germany (GRID:grid.494742.8)
21 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany (GRID:grid.411327.2) (ISNI:0000 0001 2176 9917)
22 Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095)
23 Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Institute of Translational Medicine, University of Liverpool, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
24 Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany (GRID:grid.8385.6) (ISNI:0000 0001 2297 375X); Department of Biomedicine, University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland (GRID:grid.410567.1)